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A B S T R A C T
We investigated the impact of the particle size of wheat bran on gut dysbiosis and inﬂammation induced by a
fructose overload. Mice received drinking water with or without fructose (30%) and a standard diet supple-
mented with or without 5% of wheat bran fractions characterized by diﬀerent average particle sizes (1690 µm
versus 150 µm) for 8 weeks. Fructose increased Enterobacteriaceae associated with higher expression of key in-
ﬂammatory genes in the liver. The two wheat bran fractions diﬀerently aﬀected speciﬁc gut bacteria known to be
involved in the regulation of the gut barrier function and/or inﬂammatory processes. Moreover, wheat bran with
small particle size was the sole ﬁbre that reduced hepatic and systemic inﬂammatory markers upon high fructose
intake. The anti-inﬂammatory eﬀects of wheat bran may be dependent on their particle size and could be related
to the changes in caecal Enterobacteriaceae.
1. Introduction
Consumption of reﬁned sugars has increased over the past decades.
In particular, the intake of sugars like fructose has increased sub-
stantially in the Western countries. This is largely through its use as a
sweetener in beverages and in the diet with the production of “sweet
corn-based syrups” known as “high-fructose corn syrups” (Bray,
Nielsen, & Popkin, 2004; Cordain et al., 2005; Pereira et al., 2017). The
overconsumption of fructose has been implicated as a contributing
factor in the development of metabolic diseases such as in non-alcoholic
fatty liver disease (NAFLD) and steatohepatitis (NASH) (Lim, Mietus-
Snyder, Valente, Schwarz, & Lustig, 2010; Matteoni et al., 1999;
O'Sullivan et al., 2014; Vila et al., 2011). Growing evidence supports
that increased intestinal permeability participates in fructose-induced
development of NAFLD and chronic inﬂammation. In fact, the accel-
eration of fructolysis in the intestine may cause local inﬂammation and
reduce tight junction proteins (such as occludin and zonula occludens 1
(ZO-1)) expression in intestine, leading to an increase in intestinal
permeability (Zhang, Jiao, & Kong, 2017). Alteration in the gut barrier
function results in the translocation of bacterial products like lipopo-
lysaccharides (LPS) in the portal blood ﬂow that leads to a condition
deﬁned as “metabolic endotoxemia” (Cani et al., 2008; Farhadi et al.,
2008; Ruiz et al., 2007; Thuy et al., 2008). Furthermore, high levels of
circulating inﬂammatory cytokines, which are often observed in fruc-
tose-fed animals or patients may impair intestinal mucosal integrity and
increases metabolic endotoxemia (Zhang et al., 2017). The liver due to
its anatomical links to the gut is continuously exposed to gut-derived
endotoxins delivered via portal vein and thus functions as the body ﬁrst
line of defense (Mouzaki et al., 2013). LPS activates toll-like receptors
(TLR) resulting in the stimulation of lipid peroxidation and the pro-
duction of pro-inﬂammatory mediators such as tumor necrosis factor-
alpha (TNF-α) or interleukin-6 (IL-6), and reactive oxygen species
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(ROS) which have been implicated in the development of liver in-
ﬂammation and ﬁbrosis (Spruss et al., 2009). In particular, fructose-
induced endotoxemia activates Kupﬀer cells via TLR4, which may be
partially involved in the development of NAFLD, and subsequently
trigger nuclear factor-kappa B (NF-кB) activation and TNF-α over-
production (Zhang et al., 2017). Meanwhile, ROS production also
participates in endotoxin-dependent development of NAFLD. Elevation
of plasma LPS and TNF-α levels of animals with high fructose diet, are
blunted by treatment with antibiotic or inoculation with faecal samples
from control donor rats (Di Luccia et al., 2015). Moreover, growing
evidence in this context suggests that the onset of fructose-induced
NAFLD is associated with the development of small intestine bacterial
overgrowth and gut microbiota alteration, and is counteracted by an-
tibiotic treatment in mice (Bergheim et al., 2008; Payne, Chassard, &
Lacroix, 2012; Sabate et al., 2008; Schnabl & Brenner, 2014; Shanab
et al., 2011). These ﬁndings suggest that the intestinal microbiota is one
of the key components in the progression of NAFLD and hepatic in-
ﬂammation (Le Roy et al., 2013; Payne et al., 2012; Spruss et al., 2009).
More recently, it has been shown that high intake of fructose in humans
(40 g/day) creates intestinal discomfort, linked mainly to gut fermen-
tation, in healthy subjects and even more in patients having in-
ﬂammatory bowel syndrome (Major et al., 2017). This “fructose intol-
erance” has been attributed to the fact that fructose is poorly digested,
and can thus be fermented in the colon (Fedewa & Rao, 2014). It is well
recognized that gut microbiota is considered as an environmental factor
involved in the control of metabolic alterations and inﬂammatory dis-
orders (Delzenne & Cani, 2011; Sonnenburg & Backhed, 2016). This
bacterial community plays a pivotal role in human nutrition and health
by promoting the supply of nutrients, preventing pathogen colonization
and shaping and maintaining normal mucosal immunity (Baumler &
Sperandio, 2016). Exciting research is now starting to unravel how the
composition of the microbiota can oﬀer either resistance or assistance
to invading pathogenic species (Baumler & Sperandio, 2016).
Nutritional strategies are of growing interest as a promising tool to
shape gut microbial composition, in order to improve key physiological
functions in the gut, and beyond (Carmody et al., 2015; David et al.,
2014). Dietary ﬁbres, one of the most important classes of compounds
in cereal grains play an important role in the control of several meta-
bolic disturbances clustered in the metabolic syndrome (Delzenne &
Cani, 2005; Fardet, 2010; Neyrinck & Delzenne, 2010). Wheat bran is a
major source of dietary ﬁbres, such as non-starch polysaccharides and
lignin. Arabinoxylan (AX) is the most abundant dietary ﬁbre in wheat
bran (Broekaert et al., 2011; Neyrinck & Delzenne, 2010) and accounts
for 20–30% of dry wheat bran mass, or 70% of its non-starch poly-
saccharides (Hemdane et al., 2016; Maes & Delcour, 2002). It is a
polymer with a D-xylose backbone linked with L-arabinose. Wheat bran
contains also several phytochemicals such as ferulic acid, which is the
most abundant phenolic compound of the whole-grain (Vitaglione
et al., 2015). It is well known that ferulic acid may be involved in anti-
inﬂammatory eﬀects of wheat bran or whole wheat grain demonstrated
in humans (Anson et al., 2009; Mateo Anson et al., 2011; Mateo Anson,
van den Berg, Havenaar, Bast, & Haenen, 2008; Vitaglione et al., 2015).
Moreover, wheat bran ﬁbre can deliver phenolic compounds into the
lower gut, and the slow and continuous release of ferulic acid by the
action of gut microbiota metabolism may increase circulating ferulic
acid and its metabolites, thus providing an amelioration of subclinical
inﬂammation and the long-term beneﬁts associated with whole-grain
consumption (Vitaglione et al., 2015). It is thought that processing may
release bound phytochemicals from grains but the concentration and
extractability of phytochemicals in relation to the exposed surface area
is not well documented. However, one study demonstrated that wheat
bran particle size inﬂuenced on phytochemical extractability and an-
tioxidant properties (Brewer, Kubola, Siriamornpun, Herald, & Shi,
2014). Furthermore, particle size inﬂuences the physiological eﬀects of
wheat bran such as colonic fermentation in humans (Jenkins et al.,
1999). Our previous study has demonstrated that particle size
diﬀerently aﬀects adiposity, inﬂammatory markers and gut microbiota
composition in mice (Suriano et al., 2017). Possible beneﬁcial eﬀects of
wheat bran fractions on gut microbiota and inﬂammation have never
been investigated in a model of fructose overconsumption. In addition,
the contribution of high fructose content to gut microbiota and gut
dysfunction remains poorly explored. Therefore, the objective of this
study was to evaluate in a model of fructose-induced gut dysfunction,
the eﬀects of two wheat bran fractions characterized by diﬀerent par-
ticle sizes on speciﬁc gut bacteria known to be involved in the regula-
tion of the gut barrier function and/or inﬂammatory processes, and to
unravel how these eﬀects may aﬀect inﬂammation outside the gut.
2. Materials and methods
2.1. Animals and diet intervention
Twenty-four male C57BL6 mice (9 weeks old at the beginning of the
experiment, Janvier Laboratories, France) were housed in speciﬁc pa-
thogen free (SPF) condition in groups of 3 mice per cage in a controlled
environment (12-h daylight cycle) with free access to food and water.
After one week of acclimatisation, mice were divided in 4 groups
(n= 6/group): a control group (CT) fed a standard diet (AIN93M,
Research Diets®, composition presented in Supplementary Table 1)
without supplementary sugar, a group fed a standard diet with 30% w/
v of fructose (D-fructose high purity grade, VWR) in the drinking water
(F group), a group fed a standard diet supplemented with 5% un-
modiﬁed wheat bran (average particle size of 1690 µm) and with
fructose in the drinking water (F+WB group), and a group fed a
standard diet supplemented with 5% wheat bran with small particle
size (average particle size of 150 µm) and with fructose in the drinking
water (F+WBs group). Commercial coarse wheat (Triticum aestivum L.)
bran was obtained from Dossche Mills (Deinze, Belgium) and it was
reduced in particle size with a Cyclotec 1093 Sample mill (FOSS, Hö-
ganäs, Sweden) as previously described (Jacobs, Hemdane, Dornez,
Delcour, & Courtin, 2015). The composition of the wheat bran materials
including soluble ﬁbre and insoluble ﬁbre has been detailed in
Supplementary Table S1. The free ferulic acid contents of the standard
diet supplemented with WB and WBs were 2.4mg/kg and 6.8mg/kg,
respectively whereas their Oxygen Radical Antioxidant Capacity
(ORAC) were 1.98 and 2.94mg Trolox equivalents/g, respectively (data
obtained from the accredited analytical laboratory Celabor, Belgium).
Food intake and water intake were recorded twice a week, and drinking
water (with or without fructose) was changed twice a week. The total
caloric intake was obtained by multiplying total food and water intake
(g) for 3 mice per cage (n= 2) by the caloric value of the diet and
fructose, i.e. 3.85 kcal/g and 4.00 kcal/g for CT and F groups, respec-
tively, and by assuming that the mice inside the cage ate and drank the
same quantities. The caloric value of the standard diet supplemented
with cereal fractions was calculated considering that wheat bran frac-
tions were completely processed by the gut microbiota into SCFA
available to the host and that the maximal caloric intake through this
process would be 2 kcal/g on average. After 8 weeks of dietary treat-
ment and a 6-h period of fasting, mice were anaesthetised with iso-
ﬂurane (Forene®, Abbott, Queenborough, Kent, England) before ex-
sanguination and tissue sampling. Vena cava blood was collected in
EDTA tubes and plasma was immediately collected after centrifugation
(13,000g, 3 min) and stored at −80 °C. Mice were killed by cervical
dislocation. Liver, white adipose tissues (visceral, epididymal and
subcutaneous), and gut segments (from ileum, proximal colon and
caecum) were carefully dissected, weighed and immersed in liquid ni-
trogen before storage at −80 °C. Animal experiments were approved
and performed in accordance with the guidelines of the local ethics
committee. The ethical code is 2014/UCL/MD/022. Housing conditions
were as speciﬁed by the Belgian Law of 29 May 2013, on the protection
of laboratory animals (Agreement LA 1230314).
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2.2. Analysis of the gut microbiota
Genomic DNA was extracted from the caecal content using a
QIAamp DNA Stool Mini Kit (Qiagen, Germany), including a bead-
beating step. The composition of the gut microbiota was analysed by
quantitative PCR (primers presented in Supplementary Table S2) as
previously described (Bindels et al., 2016).
2.3. Real-time quantitative PCR
Total RNA was isolated from tissues using the TriPure isolation re-
agent kit (Roche Diagnostics, Penzberg, Germany). Complementary
DNA was prepared by reverse transcription of 1 μg total RNA using the
Kit Reverse Transcription System (Promega, Madison, WI, USA). Real-
time PCR was performed with a CFX96 Touch Real-Time PCR Detection
System and software (Biorad Laboratories Ltd, UK) using SYBR Green
(Applied Biosystems, Den Ijssel, The Netherlands and Eurogentec,
Seraing, Belgium) for detection. All samples were run in duplicate in a
single 96-well reaction plate, and data were analysed according to the
2−ΔΔCT method. The purity of the ampliﬁed product was veriﬁed by
analyzing the melting curve performed at the end of ampliﬁcation. The
ribosomal protein L19 (RPL19) gene was chosen as a reference gene.
Primer sequences are presented in Supplementary Table S2.
2.4. Biochemical analysis
Concentration of TNFα, interleukin 1β (IL1β), IL6 and monocyte
chemotactic protein 1 (MCP1) were determined in 50 µl of plasma using
a multiplex immunoassay kit (Bio-Plex Cytokine Assay, Bio-Rad,
Nazareth, Belgium) and measured using Luminex technology (Bioplex,
Bio-Rad). Total lipid content were measured in the liver tissue after
extraction with chloroform–methanol (2:1) according to the Folch
method (Folch, Lees, & Sloane Stanley, 1957), as previously described
(Suriano et al., 2017). Reactive oxygen species (ROS) and lipid perox-
idation in the liver tissue (evaluated by measuring thiobarbituric acid-
reactive substances (TBARS)) were determined as previously described
(Neyrinck, Etxeberria, et al., 2017). Alanine aminotransferase (ALAT)
levels were measured in the serum as markers of liver damage using the
ALAT/GPT kit as described by the manufacturer (DiaSys Diagnostic and
Systems). All samples were run in duplicate.
2.5. Statistical analysis
Data are presented as mean ± SEM. Statistical signiﬁcance be-
tween groups was assessed using one-way ANOVA. The statistically
signiﬁcant ANOVA tests were followed by post hoc Tukey's multiple
comparison tests using GraphPad Prism software (version 5.00,
GraphPad Software, San Diego, California, USA). Within-groups var-
iances were compared using a Bartlett's test. If variances were sig-
niﬁcantly diﬀerent between groups, values were normalized by Log-
transformation before proceeding to the analysis. Diﬀerences between
groups were assessed using one-way ANOVA, followed by the Tukey
post hoc test. Data with diﬀerent superscript letters were signiﬁcantly
diﬀerent (p≤ .05) according to the post hoc ANOVA statistical ana-
lysis.
3. Results
3.1. Both wheat bran fractions induces diﬀerential and speciﬁc changes in
gut bacteria
The fructose intake via the drinking water was not signiﬁcantly
aﬀected by the wheat bran fractions (1.51 ± 0.05, 1.33 ± 0.06 and
1.28 ± 0.08 g/mouse/day for F, F+WB and F+WBs respectively;
p > .05, ANOVA) but it is important to note that the total caloric in-
take of mice in F, F+WB and WBs groups increased after 8 weeks of
Fig. 1. Impact of the two wheat bran fractions on caecal microbiota assessed by qPCR. Total bacteria (A), Biﬁdobacterium spp. (B), Lactobacillus spp. (C), Bacteroides/Prevotella spp. (D)
Akkermansia muciniphila (E) Enterobacteriaceae (F) in the caecal content of mice fed a control diet (CT), a control diet with fructose 30% w/v in the drinking water (F), a control diet
supplemented with 5% of wheat bran and fructose 30% w/v in the drinking water (F+WB) or a control diet supplemented with 5% of wheat bran with small particle size and fructose
30% w/v in the drinking water (F+WBs) for 8 weeks. Data are Whiskers plots with minimum and maximum. Data with diﬀerent superscript letters are signiﬁcantly diﬀerent at p < .05
(ANOVA).
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treatment, as compared to the CT group. However, the ﬁnal body
weight and fat mass were unaﬀected by dietary treatments
(Supplementary Fig. S1). The weight of the caecal content or caecal
tissue was not inﬂuenced by the dietary treatments (Supplementary Fig.
S1). Some bacteria known to be involved in the regulation of gut barrier
function and/or inﬂammatory processes such as Biﬁdobacterium spp.,
Lactobacillus spp., Bacteroides/Prevotella group, Enterobacteriaceae and
Akkermansia muciniphila were analysed in the caecal content by qPCR
(Fig. 1). Among those bacteria, the number of Akkermansia muciniphila
was reduced by about 10-fold after fructose supplementation as com-
pared to the CT group, although this eﬀect did not reach statistical
signiﬁcance (Fig. 1E). Surprisingly, WBs signiﬁcantly decreased its
abundance as compared to the F+WB and the CT groups. Moreover,
WBs counteracted the increase in Enterobacteriaceae numbers induced
by the fructose supplementation whereas WB supplementation had no
signiﬁcant eﬀect (Fig. 1F). In contrast, no signiﬁcant diﬀerences were
observed for total bacteria, Biﬁdobacterium spp., Lactobacillus spp.,
Bacteroides/Prevotella spp. numbers whatever the dietary treatments
(Fig. 1A–D).
3.2. Wheat bran fractions do not aﬀect markers involved in gut barrier
function
We measured the expression of secreted antimicrobial peptides
(AMP) produced by Paneth cells and/or enterocytes in the ileum and in
the colon: C-type lectin, primarily the regenerating islet-derived 3-
gamma (RegIIIγ), phospholipase A2g2 (Pla2g2), and lysozyme C (Lys).
However, AMP expression was not modiﬁed by fructose or wheat bran
supplementation (Table 1, Supplementary Table S3). In addition, other
markers involved in gut barrier function such as tight junction proteins
(claudin 3, occludin, ZO1) and mucin 2 (MUC2) were not modiﬁed in
the ileum and colon whatever the dietary treatment (Table 1,
Supplementary Table S3). In accordance with these results, the occludin
protein level in the ileum measured by western blotting analysis was
not diﬀerent between the groups (Supplementary Fig. S2). Altogether,
these data suggest that, in our experiment, fructose alone or in com-
bination or not with wheat bran fractions did not alter gut permeability
in the ileum or the colon.
3.3. Wheat bran fraction with small particle size improves inﬂammatory
state induced by fructose
Because fructose has been reported to induce intestinal inﬂamma-
tion, we analysed the expression of several macrophage markers
(CD11c, CD11b), lymphocyte markers (CD3γ, Foxp3), pattern re-
cognition receptors (TLR2, TLR4) and inﬂammatory cytokines/che-
mokines (IL6, IL1β, MCP1, TNFα, IFNγ, IL17A, IL22) in the ileum and/
or the colon (Fig. 2A and Supplementary Table S3). None of those
markers were signiﬁcantly changed whatever the dietary treatments
except for IL17A whose expression was signiﬁcantly decreased in the
ileum upon supplementation with both wheat bran fractions. The lower
expression of this cytokine was accompanied by a downregulation of
IL22 due to bran fractions (9.08 ± 4.82, 0.65 ± 0.42, 0.82 ± 0.28,
for F, F+WB and F+WBs, respectively; p > .05 ANOVA) suggesting
a downregulation of T helper 17 (Th17) cell lineage inside the ileal
tissue. In contrast to what happened in the gut, fructose supplementa-
tion signiﬁcantly increased the expression of key inﬂammatory genes in
the liver (CD11c, MCP1, TNFα) as compared to the CT group (Fig. 2B).
Importantly, WBs was the sole wheat bran fraction able to signiﬁcantly
reduce the expression of several key inﬂammatory markers.
Then, we analysed the systemic inﬂammatory status through mea-
surement of IL1β, IL6, MCP1 and TNFα in the plasma. Again, WBs was
the sole dietary treatment able to reduce signiﬁcantly the circulating
level of these cytokines/chemokines upon high fructose intake (Fig. 3).
3.4. Wheat bran fraction with small particle size slightly decreases oxidative
stress in the liver without aﬀecting fat accumulation in the liver
We evaluated some markers of hepatic oxidative stress such as
TBARS, ROS and the expression of NADPH oxidase 1 (Nox1) in the liver
tissue (Table 2). It is worth noting that the WBs group exhibited the
lowest values for all of these markers (signiﬁcantly versus the CT group
for the ROS content). Moreover, WBs mice exhibited lower level of
ALAT in the plasma as compared to the fructose supplemented-mice,
suggesting a lower liver injury but these changes were not signiﬁcant.
Fructose over-consumption slightly induced fat inﬁltration in the liver
tissue (Supplementary Fig. S3). Both wheat bran fractions did not sig-
niﬁcantly aﬀect total lipid content in the liver. This observation was
conﬁrmed by histological analysis after oil red O staining
(Supplementary Fig. S3).
3.5. Changes in the speciﬁc gut bacteria induced by wheat bran fractions
correlated with a key hepatic inﬂammatory parameter
Spearman’s correlation tests were performed to evaluate the po-
tential links between caecal bacteria and host parameters among the
four experimental groups. The most relevant correlations are shown in
Fig. 4. We found that MCP1 mRNA in the liver – which is the marker
whose expression is the most signiﬁcantly aﬀected by the dietary
treatments (fructose and WBs) – was negatively correlated with Ak-
kermansia muciniphila and positively associated with Enterobacteriaceae.
4. Discussion
In this study, we evaluated the potential health beneﬁts of two well-
characterized wheat bran fractions, in relationship with their impact on
the gut microbiota, in a mouse model of liver inﬂammation induced by
high fructose intake.
It has been previously described that adding sugars to the diet
changes the gut microbiota composition (Di Luccia et al., 2015; Ferrere
et al., 2016; Magnusson et al., 2015). Those studies showed that sugar
consumption signiﬁcantly elevated gram-negative Proteobacteria, and
more speciﬁcally within this phylum, microbes from Enterobacteriaceae
family were increased by added-sugar consumption (Ferrere et al.,
2016; Noble et al., 2017). The increase in Proteobacteria is generally
associated with gut dysbiosis and altered composition of the gut mi-
crobiota but also with an increased intestinal permeability and meta-
bolic endotoxemia (Cani et al., 2007, 2008, 2009; Shin, Whon, & Bae,
2015). In our study, high-fructose intake increased the abundance of
Enterobacteriaceae, conﬁrming previous results obtained by Ferrere
et al. (2016). Interestingly, only WBs blunted the increase of this bac-
terial family whereas Akkermansia muciniphila was increased only upon
WB supplementation. Such diﬀerence between the two fractions was
Table 1
Gene expression in the ileum.
F F+WB F+WBs
Antimicrobial peptides
Reg3γ 0.65 ± 0.14 0.77 ± 0.26 0.46 ± 0.14
Pla2g2 1.24 ± 0.27 1.02 ± 0.16 1.12 ± 0.18
Lyz 0.84 ± 0.09 0.90 ± 0.04 1.11 ± 0.21
Gut permeability markers
Claudin3 1.05 ± 0.27 1.10 ± 0.17 0.91 ± 0.06
Occludin 0.90 ± 0.20 1.23 ± 0.19 1.08 ± 0.10
Zo1 1.08 ± 0.19 1.23 ± 0.17 1.16 ± 0.08
Muc2 1.54 ± 0.66 1.48 ± 0.45 1.02 ± 0.13
Mice were fed a control diet (CT), a control diet with fructose 30% w/v in the drinking
water (F), a control diet supplemented with 5% of wheat bran and fructose 30% w/v in
the drinking water (F+WB) or a control diet supplemented with 5% of wheat bran with
small particle size and fructose 30% w/v in the drinking water (F+WBs) for 8 weeks.
Results are expressed as mean ± SEM. Values are expressed as relative units with the
mean of CT mice values set at 1; p > .05 (ANOVA).
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already observed in a model of high fat-induced obesity: only the crude
fraction of wheat bran (WB) distinguished from fraction with small
particle size (WBs) by the capacity to increase the Akkermansia genus
(Suriano et al., 2017). Interesting papers show, in vitro on Caco-2 cells,
that speciﬁc bacteria belonging to Biﬁdobacterium and Lactobacillus and
used as probiotics are able to compete with Enterobacteriaceae for en-
terocyte adhesion (Candela et al., 2008; Lee et al., 2000). Even if we do
not have any changes in lactobacilli and biﬁdobacteria in wheat bran-
treated mice, we cannot exclude that changes in bacterial environment
could also contribute to the improvement of intestinal functions by
wheat bran fractions. Previous studies in mice showed that changes in
the gut microbiota in favor of Akkermansia muciniphila or oral
administration of this bacterium improved gut barrier, metabolic
parameters and inﬂammatory disorders (Everard et al., 2013, 2011,
2014; Plovier et al., 2017). In our study, WB did not exert hepatic anti-
inﬂammatory eﬀects or changes of several markers in the ileum or the
colon regarding the gut barrier function but we observed a lower ex-
pression of IL17A in the ileum (and IL22 to a lower extent). Those
cytokines were also downregulated by the WBs fraction and may po-
tentially reﬂect Th17 cell inhibition (Sabat, Ouyang, & Wolk, 2014).
Indeed, Th17 cells belong to a recently identiﬁed T helper subset, in
addition to the traditional Th1 and Th2 subsets, and are characterized
as preferential producers of IL17A and IL22 (Ouyang, Kolls, & Zheng,
2008). It is worth mentioning that the eﬀector cytokines of Th17 cells
Fig. 2. Impact of the two wheat bran fractions on ex-
pression of inﬂammatory genes in the ileum (A) and
the liver (B). Mice were fed a control diet (CT), a
control diet with fructose 30% w/v in the drinking
water (F), a control diet supplemented with 5% of
wheat bran and fructose 30% w/v in the drinking
water (F+WB) or a control diet supplemented with
5% of wheat bran with small particle size and fructose
30% w/v in the drinking water (F+WBs) for 8 weeks.
Results are expressed as mean ± SEM. Values are ex-
pressed as relative units with the mean of CT mice
values set at 1. §p < .05 versus CT; *p < .05 versus F
(ANOVA).
Fig. 3. Impact of the two wheat bran fractions on
systemic inﬂammatory parameters. Mice were fed a
control diet (CT), a control diet with fructose 30% w/v
in the drinking water (F), a control diet supplemented
with 5% of wheat bran and fructose 30% w/v in the
drinking water (F+WB) or a control diet supple-
mented with 5% of wheat bran with small particle size
and fructose 30% w/v in the drinking water (F+WBs)
for 8 weeks. Results are expressed as percentage of CT
mice (mean ± SEM). Data with diﬀerent superscript
letters are signiﬁcantly diﬀerent at p < .05 (ANOVA).
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play indispensable roles in tissue immunity mediating host defense
mechanisms to various infections, especially extracellular bacterial in-
fections (Ouyang et al., 2008). However, the role of IL17A in gastro-
intestinal inﬂammation remains controversial (Yamada et al., 2011)
and further studies are needed to better understand the Th17 cell re-
sponse to wheat bran supplementation in the mouse model of high-
fructose intake inducing liver inﬂammation.
In our setting, we were unable to highlight a loss of the tight
junction proteins in any part of the intestine. In addition to this lack of
inﬂammatory events in the ileum or the colon, fructose consumption
did not change body weight and the amount of the fat mass. The same
observations have been previously described in mice with free access to
solutions containing either 30% or 15% of fructose in the drinking
water for 8 or 12 weeks of treatment respectively (Baena et al., 2017;
Bergheim et al., 2008). It is well known that fructose consumption in-
creases oxidative stress (Lim et al., 2010; Zhang et al., 2017). ROS and
TBARS overproduction, a common metric of oxidative stress and lipid
peroxidation, are considered as important mediators in the develop-
ment of liver damage (Dryden, Deaciuc, Arteel, & McClain, 2005). ROS
can activate several intracellular signalling pathways that can lead to
hepatocyte apoptosis (Gambino, Musso, & Cassader, 2011). In our
study, neither ROS nor TBARS contents were increased in the liver of
fructose-fed mice but the lowest level of ROS was observed upon WBs
consumption together with a decrease of ALAT activity in the serum of
F+WBs (versus the F group), suggesting a reduction in hepatic
oxidative stress and injury due to WBs supplementation.
Gut microbes dialogue with the host via speciﬁc cell membranes or
related molecules that may activate pattern recognition receptors such
as TLRs (Beutler, 2004). The interaction between microbial components
and TLRs, which are innate immune sensors present on certain immune
cells within the gut, contributes to maintenance of the mucosal and
systemic immune status (Thaiss, Zmora, Levy, & Elinav, 2016). As
shown by other authors, chronic fructose exposure induces transloca-
tion of bacterial components in the liver, and primes hepatic Kupﬀer
cells, thereby leading to inﬂammatory response, cytokine production
and chemokine-mediated recruitment of acute inﬂammatory cells
(Beutler, 2004; Spruss et al., 2009). The activation of the resident
macrophages in the liver is a key event contributing to NAFLD (Lanthier
et al., 2010; Neyrinck et al., 2009).
In the present study, and in contrast to what happened in the distal
part of the gut, several inﬂammatory markers were induced by high-
fructose intake in the liver tissue. Interestingly, WBs was the sole
fraction that blunted hepatic inﬂammation by normalizing the macro-
phage inﬁltration in this tissue through the signiﬁcant downregulation
of CD11c, MCP1 and TNFα reﬂecting the M1 macrophage phenotype.
Moreover, supplementation with WBs inhibited also the expression of
TLR2 which conﬁrms a modulation of the hepatic immune response.
The concentrations of soluble ﬁbre calculated in the diets supplemented
with WB and WBs were 2.35% and 2.34%, respectively, whereas the
concentrations of insoluble ﬁbre were 0.32% and 0.38% suggesting that
the anti-inﬂammatory eﬀects observed with WBs might not be attrib-
uted to the type of ﬁbre in the fraction. It is worth to note that both the
free ferulic acid content of the diet supplemented with WBs and its
antioxidant capacity (ORAC) were higher than their levels in the diet
supplemented with WB. It is well known that ferulic acid from aleurone
determined the antioxidant potency of wheat grain and may be in-
volved in anti-inﬂammatory eﬀects of wheat bran or whole wheat grain
demonstrated in humans (Mateo Anson et al., 2008, 2011; Vitaglione
et al., 2015). This leads us to postulate that the higher free ferulic acid
content and the higher antioxidant capacity obtained in the diet con-
taining the WBs fraction could participate in the anti-inﬂammatory
eﬀects observed in the liver of WBs-treated mice. Interestingly, En-
terobacteriaceae and Akkermansia muciniphila were correlated with
MCP1, a proinﬂammatory marker that was highly aﬀected by the
supplementation with both fructose and WBs. The fact that WBs, the
only bran fraction to signiﬁcantly aﬀect hepatic and systemic in-
ﬂammation, decreased the Enterobacteriaceae levels without aﬀecting
Akkermansia muciniphila one, suggest that the decrease in En-
terobacteriaceae could play a key part in the anti-inﬂammatory eﬀects of
WBs. It is important to note that WBs decreased inﬂammatory and
oxidative stresses in the liver without aﬀecting signiﬁcantly fat accu-
mulation in this tissue. Indeed, the mice treated with WB or WBs had
Table 2
Parameters related to oxidative stress and liver injury.
CT F F+WB F+WBs
Plasma
ALAT (U/L) 7.34 ± 1.43 11.13 ± 0.46 11.10 ± 2.93 7.99 ± 0.82
Liver
ROS content (%
RFU/µg
protein)
100 ± 4 a 87 ± 8 ab 79 ± 5 ab 68 ± 7b
TBARS content
(nmol/µg
protein)
132 ± 20 108 ± 6 100 ± 9 102 ± 15
Nox1 mRNA
(relative
expression)
1.00 ± 0.08 1.11 ± 0.16 1.11 ± 0.15 0.84 ± 0.06
Mice were fed a control diet (CT), a control diet with fructose 30% w/v in the drinking
water (F), a control diet supplemented with 5% of wheat bran and fructose 30% w/v in
the drinking water (F+WB) or a control diet supplemented with 5% of wheat bran with
small particle size and fructose 30% w/v in the drinking water (F+WBs) for 8 weeks.
Results are expressed as mean ± SEM. Data with diﬀerent superscript letters are sig-
niﬁcantly diﬀerent at p < .05 (ANOVA). ROS, reactive oxygen species; TBARS, thio-
barbituric acid reactive substances; ALAT, alanine aminotransferase.
Fig. 4. Spearman correlation analysis between the hepatic expression of MCP1 and two caecal bacteria signiﬁcantly aﬀected by the dietary treatments (Akkermansia muciniphila and
Enterobacteriaceae). Mice were fed a control diet (CT), a control diet with fructose 30% w/v in the drinking water (F), a control diet supplemented with 5% of wheat bran and fructose 30%
w/v in the drinking water (F+WB) or a control diet supplemented with 5% of wheat bran with small particle size and fructose 30% w/v in the drinking water (F+WBs) for 8 weeks.
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not signiﬁcant eﬀect on liver lipid content or on adiposity. Therefore, in
this case, we cannot see any eﬀect related to the fat binding capacity of
wheat bran that we have previously shown in a model of western diet
fed obese mice (Suriano et al., 2017). Interestingly, this study revealed
that WBs signiﬁcantly reduced systemic inﬂammatory parameters as
conﬁrmed by the reduction of four important proinﬂammatory cyto-
kines/chemokines. Altogether, our data led us to postulate that the
management of hepatic and systemic inﬂammation by WBs occurred
independently of any signiﬁcant changes in lipid accumulation and
independently of barrier alterations or immune function in the distal
part of the gut where fructose fermentation occurred. In humans, the
relationship between small intestinal bacterial overgrowth and liver
inﬂammation linked to non-alcoholic fatty liver disease has been de-
scribed, and nutritional tools like wheat bran extract could be inter-
esting in this particular context also (Kapil et al., 2016). Particle size is
another factor to be considered while considering functionality of
wheat bran in cereal products. Indeed, it inﬂuences the physico-che-
mical properties and the physiological eﬀects of wheat bran such as
colonic fermentation in humans and aﬀects adiposity, inﬂammatory
markers and gut microbiota composition in mice (Jenkins et al., 1999;
Suriano et al., 2017). In this respect, the size of particles may be fun-
damental because it may inﬂuence the fermentability of dietary ﬁbre as
well as the availability of bound polyphenols (ferulic acid) to act as
antioxidants along the gastro-intestinal tract and to be released by the
intestinal microbial communities (Brewer et al., 2014; Onipe, Jideani, &
Beswa, 2015; Vitaglione, Napolitano, & Fogliano, 2008). These factors
might have relevant implications in the systemic and hepatic anti-in-
ﬂammatory eﬀects observed only with WBs.
In conclusion, our ﬁndings support the interest of the ingestion of
some wheat bran fraction - characterized by a small particle size- in the
management of inﬂammatory disorders outside the gut, namely in the
liver. We propose that the physicochemical characteristics of the bran
fractions may contribute to selective changes in the gut microbiota,
allowing to counteract the bloom in Enterobacteriaceae, associated with
liver inﬂammation.
Acknowledgments
We thank Isabelle Blave, Remi Selleslagh and Bouazza Es Saadi for
skilful technical assistance. LBB is a recipient of FSR subsidies (UCL,
Belgium) and was a Postdoctoral Researcher from the FRS-FNRS (Fond
National de la Recherche Scientiﬁque, Belgium) when the study started.
SL is a Postdoctoral Researcher from the FRS-FNRS. NMD is a recipient
of FRS-FNRS grants and an EU grant (n°613979 MyNewGut project).
MO is a beneﬁciary of a “MOVE-IN Louvain” Incoming Post-doctoral
Fellowship co-funded by the Marie Curie Actions of the European
Commission. We thank the Flanders Innovation & Entrepreneurship
(Vlaio or ”Agentschap Innoveren & Ondernemen”, former IWT) for the
ﬁnancial support of the SBO BRANDING project. PDC, a senior research
associate at the FRS-FNRS (Belgium), is a recipient of an ERC Starting
Grant 2013 (European Research Council, Starting Grant 336452-
ENIGMO), Baillet Latour grant for medical research 2015 and is sup-
ported by the FRS-FNRS via the FRFS-WELBIO under Grant number
WELBIO-CR-2012S-02R.
Conﬂict of interest
None.
Appendix A. Supplementary material
Supplementary data associated with this article can be found, in the
online version, at http://dx.doi.org/10.1016/j.jﬀ.2017.12.035.
References
Anson, N. M., Selinheimo, E., Havenaar, R., Aura, A. M., Mattila, I., Lehtinen, P., ...
Haenen, G. R. (2009). Bioprocessing of wheat bran improves in vitro bioaccessibility
and colonic metabolism of phenolic compounds. Journal of Agriculture and Food
Chemistry, 57(14), 6148–6155.
Baena, M., Sanguesa, G., Hutter, N., Beltran, J. M., Sanchez, R. M., Roglans, N., ... Laguna,
J. C. (2017). Liquid fructose in Western-diet-fed mice impairs liver insulin signaling
and causes cholesterol and triglyceride loading without changing calorie intake and
body weight. Journal of Nutritional Biochemistry, 40, 105–115.
Baumler, A. J., & Sperandio, V. (2016). Interactions between the microbiota and patho-
genic bacteria in the gut. Nature, 535(7610), 85–93.
Bergheim, I., Weber, S., Vos, M., Krämer, S., Volynets, V., Kaserouni, S., ... Bischoﬀ, S. C.
(2008). Antibiotics protect against fructose-induced hepatic lipid accumulation in
mice: Role of endotoxin. Journal of Hepatology, 48(6), 983–992.
Beutler, B. (2004). Inferences, questions and possibilities in Toll-like receptor signalling.
Nature, 430(6996), 257–263.
Bindels, L. B., Neyrinck, A. M., Claus, S. P., Le Roy, C. I., Grangette, C., Pot, B., ...
Delzenne, N. M. (2016). Synbiotic approach restores intestinal homeostasis and
prolongs survival in leukaemic mice with cachexia. ISME Journal, 10(6), 1456–1470.
Bray, G. A., Nielsen, S. J., & Popkin, B. M. (2004). Consumption of high-fructose corn
syrup in beverages may play a role in the epidemic of obesity. American Journal of
Clinical Nutrition, 79(4), 537–543.
Brewer, L. R., Kubola, J., Siriamornpun, S., Herald, T. J., & Shi, Y. C. (2014). Wheat bran
particle size inﬂuence on phytochemical extractability and antioxidant properties.
Food Chemistry, 152, 483–490.
Broekaert, W. F., Courtin, C. M., Verbeke, K., Van de Wiele, T., Verstraete, W., & Delcour,
J. A. (2011). Prebiotic and other health-related eﬀects of cereal-derived arabinox-
ylans, arabinoxylan-oligosaccharides, and xylooligosaccharides. Critical Reviews in
Food Science and Nutrition, 51(2), 178–194.
Candela, M., Perna, F., Carnevali, P., Vitali, B., Ciati, R., Gionchetti, P., ... Brigidi, P.
(2008). Interaction of probiotic Lactobacillus and Biﬁdobacterium strains with
human intestinal epithelial cells: Adhesion properties, competition against en-
teropathogens and modulation of IL-8 production. International Journal of Food
Microbiology, 125(3), 286–292.
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., &
Burcelin, R. (2008). Changes in gut microbiota control metabolic endotoxemia-in-
duced inﬂammation in high-fat diet-induced obesity and diabetes in mice. Diabetes,
57(6), 1470–1481.
Cani, P. D., Neyrinck, A. M., Fava, F., Knauf, C., Burcelin, R. G., Tuohy, K. M., ... Delzenne,
N. M. (2007). Selective increases of biﬁdobacteria in gut microﬂora improve high-fat-
diet-induced diabetes in mice through a mechanism associated with endotoxaemia.
Diabetologia, 50(11), 2374–2383.
Cani, P. D., Possemiers, S., Van De Wiele, T., Guiot, Y., Everard, A., Rottier, O., ...
Delzenne, N. M. (2009). Changes in gut microbiota control inﬂammation in obese
mice through a mechanism involving GLP-2-driven improvement of gut permeability.
Gut, 58(8), 1091–1103.
Carmody, Rachel N., Gerber, Georg K., Luevano, Jesus M., Jr, Gatti, Daniel M., Somes, L.,
& Turnbaugh, Peter J. (2015). Diet dominates host genotype in shaping the murine
gut microbiota. Cell Host & Microbe, 17(1), 72–84.
Cordain, L., Eaton, S. B., Sebastian, A., Mann, N., Lindeberg, S., Watkins, B. A., ... Brand-
Miller, J. (2005). Origins and evolution of the Western diet: health implications for
the 21st century. American Journal of Clinical Nutrition, 81(2), 341–354.
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E.,
... Turnbaugh, P. J. (2014). Diet rapidly and reproducibly alters the human gut mi-
crobiome. Nature, 505(7484), 559–563.
Delzenne, N. M., & Cani, P. D. (2005). A place for dietary ﬁbre in the management of the
metabolic syndrome. Current Opinion in Clinical Nutrition & Metabolic Care, 8(6),
636–640.
Delzenne, N. M., & Cani, P. D. (2011). Interaction between obesity and the gut micro-
biota: relevance in nutrition. Annual Review of Nutrition, 31, 15–31.
Di Luccia, B., Crescenzo, R., Mazzoli, A., Cigliano, L., Venditti, P., Walser, J. C., ... Iossa, S.
(2015). Rescue of fructose-induced metabolic syndrome by antibiotics or faecal
transplantation in a rat model of obesity. PLoS One, 10(8), e0134893.
Dryden, G. W., Jr., Deaciuc, I., Arteel, G., & McClain, C. J. (2005). Clinical implications of
oxidative stress and antioxidant therapy. Current Gastroenterology Reports, 7(4),
308–316.
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., ... Cani, P. D.
(2013). Cross-talk between Akkermansia muciniphila and intestinal epithelium
controls diet-induced obesity. Proceedings of the National Academy of Sciences,
110(22), 9066–9071.
Everard, A., Lazarevic, V., Derrien, M., Girard, M., Muccioli, G. G., Neyrinck, A. M., ...
Cani, P. D. (2011). Responses of gut microbiota and glucose and lipid metabolism to
prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes, 60(11),
2775–2786.
Everard, A., Lazarevic, V., Gaia, N., Johansson, M., Stahlman, M., Backhed, F., ... Cani, P.
D. (2014). Microbiome of prebiotic-treated mice reveals novel targets involved in
host response during obesity. ISME Journal, 8(10), 2116–2130. http://dx.doi.org/10.
1038/ismej.2014.45.
Fardet, A. (2010). New hypotheses for the health-protective mechanisms of whole-grain
cereals: What is beyond ﬁbre? Nutrition Research Reviews, 23(1), 65–134.
Farhadi, A., Gundlapalli, S., Shaikh, M., Frantzides, C., Harrell, L., Kwasny, M. M., &
Keshavarzian, A. (2008). Susceptibility to gut leakiness: A possible mechanism for
endotoxaemia in non-alcoholic steatohepatitis. Liver International, 28(7), 1026–1033.
Fedewa, A., & Rao, S. S. (2014). Dietary fructose intolerance, fructan intolerance and
F. Suriano et al. Journal of Functional Foods 41 (2018) 155–162
161
FODMAPs. Current Gastroenterology Reports, 16(1), 370.
Ferrere, G., Leroux, A., Wrzosek, L., Puchois, V., Gaudin, F., Ciocan, D., ... Cassard, A. M.
(2016). Activation of kupﬀer cells is associated with a speciﬁc dysbiosis induced by
fructose or high fat diet in mice. PLoS One, 11(1), e0146177.
Folch, J., Lees, M., & Sloane Stanley, G. H. (1957). A simple method for the isolation and
puriﬁcation of total lipides from animal tissues. Journal of Biological Chemistry,
226(1), 497–509.
Gambino, R., Musso, G., & Cassader, M. (2011). Redox balance in the pathogenesis of
nonalcoholic fatty liver disease: Mechanisms and therapeutic opportunities.
Antioxidants & Redox Signaling, 15(5), 1325–1365.
Hemdane, S., Jacobs, P. J., Dornez, E., Verspreet, J., Delcour, J. A., & Courtin, C. M.
(2016). Wheat (Triticum aestivum L.) bran in bread making: A critical review.
Comprehensive Reviews in Food Science and Food Safety, 15(1), 28–42.
Jacobs, P. J., Hemdane, S., Dornez, E., Delcour, J. A., & Courtin, C. M. (2015). Study of
hydration properties of wheat bran as a function of particle size. Food Chemistry, 179,
296–304.
Jenkins, D. J., Kendall, C. W., Vuksan, V., Augustin, L. S., Li, Y. M., Lee, B., ... Fulgoni, V.
(1999). The eﬀect of wheat bran particle size on laxation and colonic fermentation.
Journal of the American College of Nutrition, 18(4), 339–345.
Kapil, S., Duseja, A., Sharma, B. K., Singla, B., Chakraborti, A., Das, A., ... Chawla, Y.
(2016). Small intestinal bacterial overgrowth and toll-like receptor signaling in pa-
tients with non-alcoholic fatty liver disease. Journal of Gastroenterology and
Hepatology, 31(1), 213–221.
Lanthier, N., Molendi-Coste, O., Horsmans, Y., van, R. N., Cani, P. D., & Leclercq, I. A.
(2010). Kupﬀer cell activation is a causal factor for hepatic insulin resistance 1.
American Journal of Physiology. Gastrointestinal and Liver Physiology, 298(1),
G107–G116.
Le Roy, T., Llopis, M., Lepage, P., Bruneau, A., Rabot, S., Bevilacqua, C., ... Gerard, P.
(2013). Intestinal microbiota determines development of non-alcoholic fatty liver
disease in mice. Gut, 62(12), 1787–1794.
Lee, Y. K., Lim, C. Y., Teng, W. L., Ouwehand, A. C., Tuomola, E. M., & Salminen, S.
(2000). Quantitative approach in the study of adhesion of lactic acid bacteria to in-
testinal cells and their competition with enterobacteria. Applied and Environment
Microbiology, 66(9), 3692–3697.
Lim, J. S., Mietus-Snyder, M., Valente, A., Schwarz, J. M., & Lustig, R. H. (2010). The role
of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nature Reviews
Gastroenterology & Hepatology, 7(5), 251–264.
Maes, C., & Delcour, J. A. (2002). Structural characterisation of water-extractable and
water-unextractable arabinoxylans in wheat bran. Journal of Cereal Science, 35(3),
315–326.
Magnusson, K. R., Hauck, L., Jeﬀrey, B. M., Elias, V., Humphrey, A., Nath, R., ...
Bermudez, L. E. (2015). Relationships between diet-related changes in the gut mi-
crobiome and cognitive ﬂexibility. Neuroscience, 300, 128–140.
Major, G., Pritchard, S., Murray, K., Alappadan, J. P., Hoad, C. L., Marciani, L., ... Spiller,
R. (2017). Colon hypersensitivity to distension, rather than excessive gas production,
produces carbohydrate-related symptoms in individuals with irritable bowel syn-
drome. Gastroenterology, 152(1), 124–133 e122.
Mateo Anson, N., Aura, A. M., Selinheimo, E., Mattila, I., Poutanen, K., van den Berg, R.,
... Haenen, G. R. (2011). Bioprocessing of wheat bran in whole wheat bread increases
the bioavailability of phenolic acids in men and exerts antiinﬂammatory eﬀects ex
vivo. Journal of Nutrition, 141(1), 137–143.
Mateo Anson, N., van den Berg, R., Havenaar, R., Bast, A, & Haenen, G. R. (2008). Ferulic
acid from aleurone determines the antioxidant potency of wheat grain (Triticum
aestivum L.). Journal of Agriculture and Food Chemistry, 56(14), 5589–5594.
Matteoni, C. A., Younossi, Z. M., Gramlich, T., Boparai, N., Liu, Y. C., & McCullough, A. J.
(1999). Nonalcoholic fatty liver disease: A spectrum of clinical and pathological se-
verity. Gastroenterology, 116(6), 1413–1419.
Mouzaki, M., Comelli, E. M., Arendt, B. M., Bonengel, J., Fung, S. K., Fischer, S. E., ...
Allard, J. P. (2013). Intestinal microbiota in patients with nonalcoholic fatty liver
disease. Hepatology, 58(1), 120–127.
Neyrinck, A. M., Cani, P. D., Dewulf, E. M., De, B. F., Bindels, L. B., & Delzenne, N. M.
(2009). Critical role of Kupﬀer cells in the management of diet-induced diabetes and
obesity. Biochemical and Biophysical Research Communications, 385(3), 351–356.
Neyrinck, A. M., & Delzenne, N. M. (2010). Potential interest of gut microbial changes
induced by non-digestible carbohydrates of wheat in the management of obesity and
related disorders. Current Opinion in Clinical Nutrition & Metabolic Care, 13(6),
722–728.
Neyrinck, A. M., Etxeberria, U., Taminiau, B., Daube, G., Van Hul, M., Everard, A., ...
Delzenne, N. M. (2017). Rhubarb extract prevents hepatic inﬂammation induced by
acute alcohol intake, an eﬀect related to the modulation of the gut microbiota.
Molecular Nutrition and Food Research, 61(1).
Noble, E. E., Hsu, T. M., Jones, R. B., Fodor, A. A., Goran, M. I., & Kanoski, S. E. (2017).
Early-life sugar consumption aﬀects the rat microbiome independently of obesity.
Journal of Nutrition, 147(1), 20–28.
O'Sullivan, T. A., Oddy, W. H., Bremner, A. P., Sherriﬀ, J. L., Ayonrinde, O. T., Olynyk, J.
K., ... Adams, L. A. (2014). Lower fructose intake may help protect against devel-
opment of nonalcoholic fatty liver in adolescents with obesity. Journal of Pediatric
Gastroenterology and Nutrition, 58(5), 624–631.
Onipe, O. O., Jideani, A. I. O., & Beswa, D. (2015). Composition and functionality of
wheat bran and its application in some cereal food products. International Journal of
Food Science & Technology, 50(12), 2509–2518.
Ouyang, W., Kolls, J. K., & Zheng, Y. (2008). The biological functions of T helper 17 cell
eﬀector cytokines in inﬂammation. Immunity, 28(4), 454–467.
Payne, A. N., Chassard, C., & Lacroix, C. (2012). Gut microbial adaptation to dietary
consumption of fructose, artiﬁcial sweeteners and sugar alcohols: Implications for
host-microbe interactions contributing to obesity. Obesity Reviews, 13(9), 799–809.
Pereira, R. M., Botezelli, J. D., da Cruz Rodrigues, K. C., Mekary, R. A., Cintra, D. E., Pauli,
J. R., ... de Moura, L. P. (2017). Fructose consumption in the development of obesity
and the eﬀects of diﬀerent protocols of physical exercise on the hepatic metabolism.
Nutrients, 9(4).
Plovier, H., Everard, A., Druart, C., Depommier, C., Van Hul, M., Geurts, L., ... Cani, P. D.
(2017). A puriﬁed membrane protein from Akkermansia muciniphila or the pas-
teurized bacterium improves metabolism in obese and diabetic mice. Nature Medicine,
23(1), 107–113.
Ruiz, A. G., Casafont, F., Crespo, J., Cayon, A., Mayorga, M., Estebanez, A., ... Pons-
Romero, F. (2007). Lipopolysaccharide-binding protein plasma levels and liver TNF-
alpha gene expression in obese patients: Evidence for the potential role of endotoxin
in the pathogenesis of non-alcoholic steatohepatitis. Obesity Surgery, 17(10),
1374–1380.
Sabat, R., Ouyang, W., & Wolk, K. (2014). Therapeutic opportunities of the IL-22-IL-22R1
system. Nature Reviews Drug Discovery, 13(1), 21–38.
Sabate, J. M., Jouet, P., Harnois, F., Mechler, C., Msika, S., Grossin, M., & Coﬃn, B.
(2008). High prevalence of small intestinal bacterial overgrowth in patients with
morbid obesity: A contributor to severe hepatic steatosis. Obesity Surgery, 18(4),
371–377.
Schnabl, B., & Brenner, D. A. (2014). Interactions between the intestinal microbiome and
liver diseases. Gastroenterology, 146(6), 1513–1524.
Shanab, A. A., Scully, P., Crosbie, O., Buckley, M., O'Mahony, L., Shanahan, F., ... Quigley,
E. M. (2011). Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis:
association with toll-like receptor 4 expression and plasma levels of interleukin 8.
Digestive Diseases and Sciences, 56(5), 1524–1534.
Shin, N. R., Whon, T. W., & Bae, J. W. (2015). Proteobacteria: Microbial signature of
dysbiosis in gut microbiota. Trends in Biotechnology, 33(9), 496–503.
Sonnenburg, J. L., & Backhed, F. (2016). Diet-microbiota interactions as moderators of
human metabolism. Nature, 535(7610), 56–64.
Spruss, A., Kanuri, G., Wagnerberger, S., Haub, S., Bischoﬀ, S. C., & Bergheim, I. (2009).
Toll-like receptor 4 is involved in the development of fructose-induced hepatic
steatosis in mice. Hepatology, 50(4), 1094–1104.
Suriano, F., Bindels, L. B., Verspreet, J., Courtin, C. M., Verbeke, K., Cani, P. D., ...
Delzenne, N. M. (2017). Fat binding capacity and modulation of the gut microbiota
both determine the eﬀect of wheat bran fractions on adiposity. Scientiﬁc Reports, 7(1),
5621.
Thaiss, C. A., Zmora, N., Levy, M., & Elinav, E. (2016). The microbiome and innate im-
munity. Nature, 535(7610), 65–74.
Thuy, S., Ladurner, R., Volynets, V., Wagner, S., Strahl, S., Konigsrainer, A., ... Bergheim,
I. (2008). Nonalcoholic fatty liver disease in humans is associated with increased
plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with
fructose intake. Journal of Nutrition, 138(8), 1452–1455.
Vila, L., Rebollo, A., Adalsteisson, G. S., Alegret, M., Merlos, M., Roglans, N., & Laguna, J.
C. (2011). Reduction of liver fructokinase expression and improved hepatic in-
ﬂammation and metabolism in liquid fructose-fed rats after atorvastatin treatment.
Toxicology and Applied Pharmacology, 251(1), 32–40.
Vitaglione, P., Mennella, I., Ferracane, R., Rivellese, A. A., Giacco, R., Ercolini, D., ...
Fogliano, V. (2015). Whole-grain wheat consumption reduces inﬂammation in a
randomized controlled trial on overweight and obese subjects with unhealthy dietary
and lifestyle behaviors: Role of polyphenols bound to cereal dietary ﬁber. American
Journal of Clinical Nutrition, 101(2), 251–261.
Vitaglione, P., Napolitano, A., & Fogliano, V. (2008). Cereal dietary ﬁbre: A natural
functional ingredient to deliver phenolic compounds into the gut. Trends in Food
Science & Technology, 19(9), 451–463.
Yamada, S., Naito, Y., Takagi, T., Mizushima, K., Hirai, Y., Horie, R., ... Yoshikawa, T.
(2011). Reduced small-intestinal injury induced by indomethacin in interleukin-17A-
deﬁcient mice. Journal of Gastroenterology and Hepatology, 26(2), 398–404.
Zhang, D. M., Jiao, R. Q., & Kong, L. D. (2017). High dietary fructose: Direct or indirect
dangerous factors disturbing tissue and organ functions. Nutrients, 9(4).
F. Suriano et al. Journal of Functional Foods 41 (2018) 155–162
162
